Dimango et al[ 56 ] showed a trend towards earlier and more frequent exacerbations in patients receiving PPIs therapy; Pauwels et al[ 58 ] demonstrated that PPIs therapy in CF patients resulted paradoxically in increased inflammatory effects on the airway.
← all excerpts
Focus on gastroesophageal reflux disease in patients with cystic fibrosis.
1
—
—